We are looking for people to take part in a new study investigating the best route of delivery for a new investigative treatment for Rheumatoid Arthritis called TolDC. TolDC is a new medicine that is developed from a person's own white blood cells.

The main criteria to take part are that you must be an adult (aged 18 or over), have had a diagnosis of Rheumatoid Arthritis (RA) for at least 4 months but less than 10 years, and be on stable medication for your RA.

There are more detailed inclusion/exclusion criteria, and the research team will discuss these with you to see if you are eligible to take part. The study is taking place at The Newcastle upon Tyne Hospitals NHS Foundation Trust.

‎